Evidence map›Paper›PMID 38553443›Full record

ArticleNature communications2024

Structural basis of Acinetobacter type IV pili targeting by an RNA virus.

Ran Meng, Zhongliang Xing, Jeng-Yih Chang, Zihao Yu, Jirapat Thongchol, Wen Xiao, Yuhang Wang, Karthik Chamakura, Zhiqi Zeng, Fengbin Wang and 3 more

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
4.6field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Super-Resolution solid-state NMR Spectroscopy.Journal of biomolecular NMR · 2026
    Article
  7. Suppressing Transfer of Antibiotic Resistance by a Small RNA Virus.bioRxiv : the preprint server for biology · 2026
    Article
  8. Review
  9. Engineered Proteins Mimic ssRNA Phage to Disrupt Type IV Pili.bioRxiv : the preprint server for biology · 2025
    Article
  10. Article
  11. Phenotypic Characterization ofAntibiotics (Basel, Switzerland) · 2025
    Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 5 institutions in 1 country.

Ran Meng *Center for Phage Technology, Department of Biochemistry and Biophysics, Texas A&M University, College Station, TX, 77843, USA.ORCID http://orcid.org/0000-0003-1271-3975
Zhongliang Xing *Center for Phage Technology, Department of Biochemistry and Biophysics, Texas A&M University, College Station, TX, 77843, USA.ORCID http://orcid.org/0000-0003-2142-6230
Jeng-Yih Chang *Center for Phage Technology, Department of Biochemistry and Biophysics, Texas A&M University, College Station, TX, 77843, USA.
Zihao YuCenter for Phage Technology, Department of Biochemistry and Biophysics, Texas A&M University, College Station, TX, 77843, USA.
Jirapat ThongcholCenter for Phage Technology, Department of Biochemistry and Biophysics, Texas A&M University, College Station, TX, 77843, USA.
Wen XiaoCenter for Phage Technology, Department of Biochemistry and Biophysics, Texas A&M University, College Station, TX, 77843, USA.
Yuhang WangCenter for Phage Technology, Department of Biochemistry and Biophysics, Texas A&M University, College Station, TX, 77843, USA.ORCID http://orcid.org/0000-0002-8048-138X
Karthik ChamakuraCenter for Phage Technology, Department of Biochemistry and Biophysics, Texas A&M University, College Station, TX, 77843, USA.ORCID http://orcid.org/0000-0002-6196-8571
Zhiqi ZengCenter for Phage Technology, Department of Biochemistry and Biophysics, Texas A&M University, College Station, TX, 77843, USA.
Fengbin WangDepartment of Biochemistry and Molecular Genetics, Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, AL, 35294, USA.ORCID http://orcid.org/0000-0003-1008-663X
Ry YoungCenter for Phage Technology, Department of Biochemistry and Biophysics, Texas A&M University, College Station, TX, 77843, USA.ORCID http://orcid.org/0000-0001-8001-2914
Lanying ZengCenter for Phage Technology, Department of Biochemistry and Biophysics, Texas A&M University, College Station, TX, 77843, USA.ORCID http://orcid.org/0000-0002-8074-5824
Junjie ZhangCenter for Phage Technology, Department of Biochemistry and Biophysics, Texas A&M University, College Station, TX, 77843, USA. junjiez@tamu.edu.ORCID http://orcid.org/0000-0002-7912-0819
Texas A&M University · USReata Pharmaceuticals (United States) · USUMass Memorial Health Care · USUniversity of Alabama at Birmingham · USYale University · US

Funding

RNA penetrations into bacteria.R01GM141659 · NIGMS · TEXAS A&M AGRILIFE RESEARCH · PI ZHANG, JUNJIE · 2022 to 2025
$2.3M
Reducing Virulence Through the Suppression of Retractile PiliR21AI156846 · NIAID · TEXAS A&M AGRILIFE RESEARCH · PI ZENG, LANYING, ZHANG, JUNJIE · 2021 to 2022
$395k
NIAID NIH HHS R21 AI156846NIGMS NIH HHS R01 GM141659
6 · The paper itself

Abstract

Acinetobacters pose a significant threat to human health, especially those with weakened immune systems. Type IV pili of acinetobacters play crucial roles in virulence and antibiotic resistance. Single-stranded RNA bacteriophages target the bacterial retractile pili, including type IV. Our study delves into the interaction between Acinetobacter phage AP205 and type IV pili. Using cryo-electron microscopy, we solve structures of the AP205 virion with an asymmetric dimer of maturation proteins, the native Acinetobacter type IV pili bearing a distinct post-translational pilin cleavage, and the pili-bound AP205 showing its maturation proteins adapted to pilin modifications, allowing each phage to bind to one or two pili. Leveraging these results, we develop a 20-kilodalton AP205-derived protein scaffold targeting type IV pili in situ, with potential for research and diagnostics.

Indexed as

AcinetobacterBacteriophagesRNA VirusesCryoelectron MicroscopyFimbriae, BacterialFimbriae ProteinsHumansFimbriae Proteins

Identifiers

PMID38553443
PMCPMC10980823
OpenAlexW4393313306

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.